![Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c5def381-c67b-46da-881e-29654ef69718/pros24414-fig-0003-m.jpg)
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t2.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
![Author Correction: Pretreatment PSA levels affects the completion rate of Ra-223 treatment | Scientific Reports Author Correction: Pretreatment PSA levels affects the completion rate of Ra-223 treatment | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-96170-5/MediaObjects/41598_2021_96170_Fig1_HTML.png)
Author Correction: Pretreatment PSA levels affects the completion rate of Ra-223 treatment | Scientific Reports
![Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies | Prostate Cancer and Prostatic Diseases Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-021-00456-8/MediaObjects/41391_2021_456_Fig1_HTML.png)
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies | Prostate Cancer and Prostatic Diseases
![Passing-Bablok regression analysis and mean bias estimates of measured... | Download Scientific Diagram Passing-Bablok regression analysis and mean bias estimates of measured... | Download Scientific Diagram](https://www.researchgate.net/publication/346923125/figure/tbl2/AS:967189876178946@1607607444609/Passing-Bablok-regression-analysis-and-mean-bias-estimates-of-measured-total-and-free-PSA.png)